← back to search

Yong Wang

Qingdao University · CN
Area of research
Biomaterials · Biomedical Engineering
Research interest
Research interests include Nanoparticle-Based Drug Delivery, Nanoplatforms for cancer theranostics, MicroRNA in disease regulation, and RNA Interference and Gene Delivery.
h-index
53
citations
11,804
works
323
NIH funding
primary concept
Medicine
email

Recent publications

Microbial metabolism dysfunction induced by transarterial chemoembolization aggravates postprocedural liver injury in HCC
Journal of Hepatology 2026cited by 5position: contributordoi
A nanodrug provokes antitumor immune responses via synchronous multicellular regulation for enhanced cancer immunotherapy
Journal of Colloid and Interface Science 2025cited by 9position: contributordoi
Adrenomedullin Inhibits the Efficacy of Combined Immunotherapy and Targeted Therapy in Biliary Tract Cancer by Disrupting Endothelial Cell Functions
Journal of Cellular and Molecular Medicine 2025cited by 5position: middledoi
A polymeric nanovesicle delivers sulfopin and gemcitabine to remodel tumor microenvironment for enhanced chemoimmunotherapy against orthotopic pancreatic cancer
Materials Today Bio 2025cited by 4position: contributordoi
High Trop-2 expression in pulmonary sarcomatoid carcinoma reveals antibody–drug conjugate targeting Trop-2 is a promising therapeutic approach
Journal of Translational Medicine 2025cited by 2position: middledoi
Anti-inflammatory effect of lignans from flaxseed after fermentation by lactiplantibacillus plantarum SCB0151 in vitro
World Journal of Microbiology and Biotechnology 2024cited by 5position: middledoi
Reduction-sensitive polymeric carrier for the targeted delivery of a quinazoline derivative for enhanced generation of reactive oxygen species against cancer.
2024cited by 3position: contributordoi
Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation.
2023cited by 52position: contributordoi
Nanodrug removes physical barrier to promote T-cell infiltration for enhanced cancer immunotherapy
Journal of Controlled Release 2023cited by 39position: middledoi
Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma
Acta Biomaterialia 2023cited by 38position: middledoi
A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer
Acta Biomaterialia 2023cited by 35position: middledoi
Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation.
2023cited by 31position: contributordoi
Nanodrug removes physical barrier to promote T-cell infiltration for enhanced cancer immunotherapy.
2023cited by 29position: contributordoi
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma
Journal for ImmunoTherapy of Cancer 2023cited by 24position: middledoi
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
2023cited by 20position: contributordoi
PEG-Sheddable Nanodrug Remodels Tumor Microenvironment to Promote Effector T Cell Infiltration and Revise Their Exhaustion for Breast Cancer Immunotherapy.
2023cited by 12position: contributordoi
A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer.
2023cited by 12position: contributordoi
Neutrophil Extracellular Traps (NETs) Promote Non-Small Cell Lung Cancer Metastasis by Suppressing lncRNA MIR503HG to Activate the NF-κB/NLRP3 Inflammasome Pathway
Frontiers in Immunology 2022cited by 106position: firstdoi
Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation
Bioactive Materials 2022cited by 59position: middledoi
The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma
Frontiers in Immunology 2022cited by 28position: middledoi
rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy
BMC Cancer 2022cited by 9position: firstdoi
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
The Lancet Oncology 2021cited by 399position: middledoi
Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy
Biomaterials 2021cited by 203position: middledoi
Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy.
2021cited by 131position: contributordoi
Multifunctional Nanodrug Mediates Synergistic Photodynamic Therapy and MDSCs‐Targeting Immunotherapy of Colon Cancer
Advanced Science 2021cited by 127position: middledoi
Nanomedicine Directs Neuronal Differentiation of Neural Stem Cells via Silencing Long Noncoding RNA for Stroke Therapy
Nano Letters 2021cited by 64position: middledoi
Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy
ACS Applied Materials & Interfaces 2021cited by 55position: middledoi
Core-shell lipoplexes inducing active macropinocytosis promote intranasal delivery of c-Myc siRNA for treatment of glioblastoma
Acta Biomaterialia 2021cited by 53position: middledoi
Nanomedicine Directs Neuronal Differentiation of Neural Stem Cells via Silencing Long Noncoding RNA for Stroke Therapy.
2021cited by 48position: contributordoi
A photo and tumor microenvironment activated nano-enzyme with enhanced ROS generation and hypoxia relief for efficient cancer therapy.
2021cited by 17position: contributordoi

Grants

EFRI E3P: A novel sequential catalytic solvolysis process for deconstructing municipal waste plastics
NSF2132219$2,000,0002021–2027PIRePORTER
I-Corps: Development of Bent DNA Molecules as Amplifying Sensors
NSF2129225$50,0002021–2023PIRePORTER
REU Site in IoT Security
NSF1852145$377,4872019–2023PIRePORTER
IIBR Instrumentation: Collaborative Research: Development of a Single-Biomolecule Detection Instrument via Digital Counting of Nanoparticles
NSF1911764$180,0002019–2023PIRePORTER
Understanding the antimicrobial mechanism of metal nanoparticles using super resolution fluorescence microscopy
NSF1826642$498,9832018–2022PIRePORTER
Growth of Hybrid Polymeric Nanostructures for Enzyme-Free Amplified Protein Imaging
NSF1802953$318,6962018–2022PIRePORTER
CAREER: Creation of Complex Biomimetic Materials via Molecular Recognition
NSF1332351$453,2362013–2018PIRePORTER
INSPIRE: Programming Materials via Biomolecular Engineering
NSF1322332$399,3572013–2018PIRePORTER
Reversible Cell Capture and Release for Cell Separation
NSF1340173$207,0392013–2014PIRePORTER
MRI: Acquisition of Equipment to Establish Mobile Testing Infrastructure for Bring Your Own Device Research and Education
NSF1337529$168,0762013–2017PIRePORTER
Controlling Protein Release via Intermolecular Hybridization
NSF1342893$107,3492013–2013PIRePORTER
RET Site in Cyber Security
NSF1200648$500,0002012–2015PIRePORTER
INSPIRE: Programming Materials via Biomolecular Engineering
NSF1241461$400,0002012–2013PIRePORTER
MRI: Acquisition of an Online Banking System for Information Assurance Research
NSF1123220$400,0002011–2015PIRePORTER
REU Site in China: Ecological and Environmental Research in Urbanized Landscape
NSF1063101$323,0692011–2014PIRePORTER
Controlling Protein Release via Intermolecular Hybridization
NSF0967512$322,8392010–2013PIRePORTER
Reversible Cell Capture and Release for Cell Separation
NSF1033212$297,1102010–2013PIRePORTER
CAREER: Creation of Complex Biomimetic Materials via Molecular Recognition
NSF0955358$274,6172010–2013PIRePORTER
Multivalent "Artificial Antibody" Based on RNA/Dendrimer-Like Star Polymer Hybrid Nanomaterials
NSF0705716$468,0002007–2010PIRePORTER
REU Site: Research Experience in Environmental and Natural Resource Sciences
NSF0649248$244,7592007–2012PIRePORTER

Frequent collaborators

Xintao Shuai · Sun Yat-sen University36 papers (2014–2023) · 15 papers (2019–2026) · 13 papers (2019–2023)Hong Xiao · Sun Yat-sen University12 papers (2014–2023)Bo Li · Kunming University of Science and Technology12 papers (2019–2023)Zecong Xiao · Sun Yat-sen University7 papers (2020–2023)Liteng Lin · Guangdong University of Technology7 papers (2018–2023)Yongcheng An · Beijing University of Chinese Medicine6 papers (2020–2021)Fang Chen · Guangzhou University of Chinese Medicine5 papers (2020–2025)Jun Shen · Fujian Medical University5 papers (2014–2021)Kangshun Zhu · Zhejiang Chinese Medical University5 papers (2018–2023)Jingjun Huang · Guangdong University of Technology4 papers (2020–2023)Mingyue Cai · Guangzhou University4 papers (2020–2023)Shisong Han · Zhuhai People's Hospital4 papers (2020–2023)Jinsheng Huang · Sun Yat-sen University4 papers (2020–2023)Xiaoying Qian · Nanchang University4 papers (2022–2025)Liejing Lu · Sun Yat-sen University3 papers (2014–2021)Shangkun Yuan · Nanchang University3 papers (2022–2022)Biao Yu · Nanchang University3 papers (2022–2025)Wensou Huang · Second Affiliated Hospital of Guangzhou Medical University3 papers (2020–2023)